Agreed Chris- I think this can reach at least 50c before an up list and potentially a buck. We are sitting at 96 million in market cap. If we get 100mil from a partner from Lympro, there's your double in share price, (so 26c at least on that news alone) plus revenue guidance, analyst estimates, grant money, RP, Eltop, another surprise partner. This thing could reach a buck or more before any RS happens, if at all.